Entries by Nexreg

Dec. 13 – REACH: Commission welcomes agreement on new chemical legislation

The European Commission welcomes the Council’s political agreement on a comprehensive new system aimed at ensuring greater safety in the manufacture and use of chemical substances. The new system, REACH, will establish an integrated system for the registration, evaluation, authorisation and restriction of chemicals. REACH will ensure that the gaps in existing information on the […]

Dec. 12 – Amendments to the Non-domestic Substances List (NDSL)

1. Part I of the Non-domestic Substances List (see footnote 1) is amended by deleting the following: 5719-73-3 52320-66-8 126990-35-0 13587-19-4 70983-77-6 145417-44-3 15217-42-2 74499-71-1 216439-38-2 17865-32-6 82168-31-8 38783-61-8 84434-11-7 – 2. Part II of the List is amended by deleting the following: 14424-6 Rosin, maleated, polymer with an alkylphenol, formaldehyde, pentaerythritol and polymerized rosin […]

Dec. 8 – FDA Advising of Risk of Birth Defects with Paxil

The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression and […]

Dec. 7 – CPSC Signs MOU with Mexico to Improve Safety of Consumer Products

The U.S. Consumer Product Safety Commission (CPSC) today announced an agreement with the Mexican government aimed at further improving consumer safety and making both the United States and Mexican marketplaces among the safest in the world. This agreement is also part of the “Security and Prosperity Partnership” between the U.S., Mexico, and Canada. CPSC Chairman […]

Dec. 7 – FDA Seeks Input on Communication of Drug Safety Information

As part of the Food and Drug Administration’s continued commitment to improve communication about risks posed by prescription medications, its Center for Drug Evaluation and Research (CDER) is holding a public meeting today to evaluate current practices and to explore new tools and strategic partnerships to enhance future efforts. “In the past year we have […]

Dec. 5 – OSHA and SCHC Renew Alliance to Improve Hazcom and MSDS

Acting Assistant Secretary of Labor for Occupational Safety and Health Jonathan L. Snare today signed a two-year renewal of the Society for Chemical Hazard Communication (SCHC) Alliance that will continue to focus on providing information and education on hazard communication and chemical safety. Through the OSHA and SCHC Alliance renewal, the organizations will continue to […]

Nov. 29 – Final Significant New Use Rule Issued for 2-ethoxyethanol, 2-ethoxyethanol acetate, 2-methoxyethanol, and 2-methoxyethanol acetate

EPA is issuing a significant new use rule (SNUR) under section 5(a)(2) of the Toxic Substances Control Act (TSCA) which requires persons to notify EPA at least 90 days before commencing the manufacture, import, or processing of 2-ethoxyethanol (CAS No. 110-80-5) (2-EE), 2-ethoxyethanol acetate (CAS No. 111-15-9) (2-EEA), 2- methoxyethanol (CAS No. 109-86-4) (2-ME), or […]

Nov. 28 – Validation Documentation Requirements and Responsibilities for Drug Fabricators, Packagers / Labellers, Testers, Distributors and Importers

A new version of the document entitled “Validation Documentation Requirements and Responsibilities for Drug Fabricators, Packagers / Labellers, Testers, Distributors and Importers” is now available. This document has been reviewed as part of the Inspectorate’s quality management process and has been amended to further clarify issues brought to the attention of the Inspectorate. Source